Literature DB >> 26985284

Inhibition of Histone Demethylases Offers a Novel and Promising Approach for the Treatment of Cancer and Other Diseases.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2015        PMID： 26985284      PMCID： PMC4753538          DOI： 10.1021/acsmedchemlett.5b00437

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.

Authors:  Zhanxin Wang; Dinshaw J Patel
Journal:  Q Rev Biophys       Date:  2013-09-02       Impact factor: 5.318

Review 2.  Chromatin proteins and modifications as drug targets.

Authors:  Kristian Helin; Dashyant Dhanak
Journal:  Nature       Date:  2013-10-24       Impact factor: 49.962

Review 3.  Histone methylases as novel drug targets: developing inhibitors of EZH2.

Authors:  Catherine Baugé; Céline Bazille; Nicolas Girard; Eva Lhuissier; Karim Boumediene
Journal:  Future Med Chem       Date:  2014       Impact factor: 3.808

Review 4.  Histone lysine demethylases as targets for anticancer therapy.

Authors:  Jonas W Højfeldt; Karl Agger; Kristian Helin
Journal:  Nat Rev Drug Discov       Date:  2013-11-15       Impact factor: 84.694
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.